Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. OrBion Pharmaceuticals Private Limited
FDA Inspection
•OrBion Pharmaceuticals Private Limited•September 8, 2023

OrBion Pharmaceuticals Private Limited – FDA Inspection, Sep 8, 2023

Record Details

This FDA Inspection record concerns OrBion Pharmaceuticals Private Limited, with an inspection on September 8, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
OrBion Pharmaceuticals Private Limited
Inspection Date
September 8, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Lillian S. Wu (Issuing Officer)
  • Nicole E. Knowlton (FDA Associated Person)
View Company Profile

ID · 4a0112db-957b-4de5-a93b-486789241983

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1217144
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

6
  1. 21 CFR 211.63Equipment Design, Size and Location
  2. 21 CFR 211.160(a)Following/documenting laboratory controls
  3. 21 CFR 211.100(a)Absence of Written Procedures
  4. 21 CFR 211.100(a)Absence of Written Procedures
  5. 21 CFR 211.160(a)Following/documenting laboratory controls
  6. 21 CFR 211.63Equipment Design, Size and Location

Full citation text and observation details available on the Dashboard.

Other FDA inspections of OrBion Pharmaceuticals Private Limited

7
DateClassificationOfficeProject area
October 27, 2025OAIGeneric Drug Evaluation
May 10, 2024Not classifiedOffice of Inspections and Investigations
May 31, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 15, 2016Not classifiedOffice of Inspections and Investigations
June 3, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for OrBion Pharmaceuticals Private Limited
  • FDA Inspection 1289382 - 2025-10-27
  • FDA Inspection 1240651 - 2024-05-10
  • FDA Inspection 1091278 - 2019-05-31
  • FDA Inspection 1001296 - 2016-12-15
  • FDA Inspection 934390 - 2015-06-03

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore OrBion Pharmaceuticals Private Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.